Key Facts

PIPS Key Facts
Active Substance
Active Substance:
Invented Name
PIP Number MHRA-100074-PIP01-21
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Prolonged-release tablets
Therapeutic area
  • Neurology
  • Pain
Conditions / Indications
Conditions / Indications:
  • Treatment of Postherpetic Neuralgia
Route(s) of administration
Route(s) of administration:
  • Oral use
PIP applicant
Decision Type
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
Compliance Check
Compliance Check
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

PIPS Decision Documents
Decision Document Decision Document on a Paediatric Investigation Plan (PIP):GABAPENTIN.pdf
Published Date 17/12/2021